Press release
Pharmaceutical Manufacturing Market Report Examines Industry Trends, Growth Drivers And Future Outlook
Pharmaceutical Manufacturing Market
Pharmaceutical Manufacturing Market Size and Growth Outlook
The pharmaceutical manufacturing market is projected to reach a substantial size of $923.47 billion by 2030, expanding at a compound annual growth rate (CAGR) of 10.0%. This surge is driven by several key factors including the rise in investments toward smart manufacturing facilities, the growing adoption of biologics production technologies, and the development of personalized medicine manufacturing. Additionally, the market benefits from a stronger focus on cost-efficient production models and increased use of digital quality management systems. Among the prominent trends influencing this growth are continuous manufacturing technologies, the rising production of biologics and biosimilars, advanced quality control systems, integration of automation and robotics, and stringent regulatory compliance measures.
The pharmaceutical manufacturing market size has grown rapidly in recent years. It will grow from $572.33 billion in 2025 to $630.77 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to expansion of global drug demand, growth in chronic disease prevalence, increasing investments in manufacturing capacity, advancement of formulation technologies, strengthening of regulatory quality standards.
Download a free sample of the pharmaceutical manufacturing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24375&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Primary Factors Stimulating Pharmaceutical Manufacturing Expansion
One of the main contributors to market growth is the increasing investment in smart manufacturing infrastructure, which enables more efficient and precise drug production. These advanced facilities incorporate cutting-edge technologies to optimize operations, reduce waste, and enhance scalability.
Moreover, there is a noticeable shift toward manufacturing biologics and biosimilars, which are complex therapies requiring specialized production capabilities. This focus aligns with the broader trend in healthcare toward targeted and personalized treatments, pushing manufacturers to innovate and adapt.
Key Industry Leaders in Pharmaceutical Manufacturing
The pharmaceutical manufacturing landscape is shaped by several influential companies, including Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, Cipla Limited, Samsung Biologics, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Lupin Limited, and Jubilant Pharmova Limited.
A significant development was Novo Holdings A/S's acquisition of Catalent for $16.5 billion in December 2024. This strategic move aims to strengthen Novo Holdings' position in life sciences by leveraging Catalent's expertise in drug development, manufacturing, and clinical supply services, accelerating growth and improving patient outcomes across pharmaceutical and biotechnology sectors.
View the full pharmaceutical manufacturing market report:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-manufacturing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Innovations and Emerging Trends in Pharmaceutical Manufacturing
Leading companies are increasingly investing in advanced manufacturing solutions to improve efficiency and quality. One notable innovation is the creation of fully automated radioligand therapy (RLT) manufacturing facilities designed to meet the rising demand for targeted cancer treatments. These state-of-the-art plants utilize automation to ensure consistent, scalable, and high-quality production of radioligand therapies.
For example, in January 2024, Novartis AG received FDA approval for Pluvicto production at a cutting-edge RLT facility in Indianapolis. This new site is set to significantly boost the company's capacity to manufacture radioligand therapies like Pluvicto and Lutathera, supporting Novartis' strategic goal to expand global access to targeted cancer therapies and improve patient care.
Segment Analysis Driving Growth in Pharmaceutical Manufacturing
This market is segmented across several categories to capture its complex scope:
1) Molecule Type: Biologics and Biosimilars, Conventional Drugs
2) Formulation: Tablets, Capsules, Injectables, Sprays, Suspensions, Powders, and Other Formulations
3) Route of Administration: Oral, Topical, Parenteral, Inhalation, and Others
4) Therapy Area: Cardiovascular Diseases, Pain, Diabetes, Cancer, Respiratory Diseases, and Other Diseases
5) Sales Channel: Retail and Non-retail
Further subsegments include:
- For Biologics and Biosimilars: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell Therapies, Gene Therapies, Hormones, Blood and Plasma Products
- For Conventional Drugs: Analgesics, Antipyretics, Antibiotics, Antivirals, Antifungals, Antihypertensives, Antidepressants, and Antidiabetics
These detailed classifications help stakeholders understand the diverse product types and therapeutic applications fueling the pharmaceutical manufacturing market's expansion.
Key enhancements in our 2026 market reports include:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Manufacturing Market Report Examines Industry Trends, Growth Drivers And Future Outlook here
News-ID: 4612803 • Views: …
More Releases from The Business Research Company
Plasmid DNA Manufacturing Market Study Explores Industry Growth Toward $7.63 Bil …
The plasmid DNA manufacturing market is positioned for remarkable expansion as advancements in biotechnology continue to accelerate. Driven by increasing applications in vaccines and gene therapies, this sector is attracting significant attention from investors and industry leaders alike. Below is an overview of market value projections, leading companies, emerging trends, and segmentation details that outline the current and future landscape of this important industry.
Plasmid DNA Manufacturing Market Size and Growth…
Plant Biotechnology Equipment Market Research Reveals Path To $23.85 Billion By …
The plant biotechnology equipment sector is on the brink of significant expansion, driven by technological innovations and increasing demand for advanced agricultural solutions. This analysis explores the market's anticipated growth, major industry players, key technological trends, and detailed segment insights to provide a clear understanding of its future trajectory.
Projected Market Size and Growth Potential in Plant Biotechnology Equipment
The plant biotechnology equipment market is expected to achieve substantial growth,…
Pigmentation Disorders Treatment Market Demonstrates Long-Term Growth Potential …
The market for pigmentation disorders treatment is poised for significant expansion in the coming years, driven by advances in dermatological care and personalized treatment approaches. As technology and research continue to evolve, this sector is expected to see dynamic growth fueled by new treatment methods and increasing consumer demand for effective skin solutions.
Market Size Outlook and Growth Trajectory for Pigmentation Disorders Treatment
The pigmentation disorders treatment market is anticipated…
Physiological Monitors Market Analysis Highlights Growth To $196.49 Billion By 2 …
An Overview of Growth in the Physiological Monitors Market
The physiological monitors market is set for significant expansion over the coming years. Forecasts predict the market will reach a valuation of $196.49 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.5%. This surge is driven by multiple factors including the rising use of home-based monitoring devices, increased investments in connected healthcare frameworks, advancements in AI-powered…
More Releases for Pharmaceutical
Metronidazole Market 2023 Latest Innovations and Outlook By Players - Hongyuan P …
The Metronidazole Market 2023 study focuses on a global evaluation of information from the most recent market developments. The purpose of MarketsandResearch.biz is to offer the company's customers a comprehensive market overview to formulate development plans.
Designing of the report is done with the help of infographics, charts, and graphs. The report initially analyzes the various segments of the global Metronidazole market in a brief manner, which includes product types, applications.…
Hyperthyroidism Treatment Market Analytical Overview and Future | Merck, Herbran …
The Hyperthyroidism Treatment market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development…
Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong …
Global Mevastatin Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for…
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma …
Global Specialty Pharmaceutical Industry Synopsis:
The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers.
The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%…
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in…
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in North…
